Abstract
In medicine, objects that need to be removed later - such as stents - are commonly placed in patients, with the time of removal dependent on progress of the patient. In these cases biodegradable materials that last for a specific time may not be suitable. We propose a new class of nanostructured materials that can hold their form as long as wanted, Triggered, Nanostructured Biodegradables (TNBs), that can be disintegrated to micro- or nanoscaled components when externally triggered on command to do so. DNA nanotensegrity microstructures, metastable foams, nanobots and other bioinspired disintegratable scaffold structures are given as potential examples.
Keywords: braces, Prince Rupert's drops, modular nanobot dental, nanobots, tensegrity, stents, surgical implants, Triggered nanostructured biodegradables, tektites
Micro and Nanosystems
Title: Triggered, Nanostructured Biodegradables (TNBs) for Surgical Implants
Volume: 3 Issue: 4
Author(s): Richard Gordon, Stephen M. Levin and Ille C. Gebeshuber
Affiliation:
Keywords: braces, Prince Rupert's drops, modular nanobot dental, nanobots, tensegrity, stents, surgical implants, Triggered nanostructured biodegradables, tektites
Abstract: In medicine, objects that need to be removed later - such as stents - are commonly placed in patients, with the time of removal dependent on progress of the patient. In these cases biodegradable materials that last for a specific time may not be suitable. We propose a new class of nanostructured materials that can hold their form as long as wanted, Triggered, Nanostructured Biodegradables (TNBs), that can be disintegrated to micro- or nanoscaled components when externally triggered on command to do so. DNA nanotensegrity microstructures, metastable foams, nanobots and other bioinspired disintegratable scaffold structures are given as potential examples.
Export Options
About this article
Cite this article as:
Gordon Richard, M. Levin Stephen and C. Gebeshuber Ille, Triggered, Nanostructured Biodegradables (TNBs) for Surgical Implants, Micro and Nanosystems 2011; 3 (4) . https://dx.doi.org/10.2174/1876402911103040284
DOI https://dx.doi.org/10.2174/1876402911103040284 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High Doses of In vitro Beta-carotene, Alpha-Tocopherol and Ascorbic Acid Induce Oxidative Stress and Secretion of IL-6 in Peripheral Blood Mononuclear Cells from Healthy Donors
Current Aging Science Mechanisms of Interferon Mediated Anti-Viral Resistance
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology The Two Faces of Interleukin-17A in Atherosclerosis
Current Drug Targets Effects of Honey Against the Accumulation of Adipose Tissue and the Increased Blood Pressure on Carbohydrate-Induced Obesity in Rat
Letters in Drug Design & Discovery New Development and Application of Ultrasound Targeted Microbubble Destruction in Gene Therapy and Drug Delivery
Current Gene Therapy Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Current Pharmaceutical Biotechnology Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Current Drug Targets microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design Pharmacological and Clinical Applications of Natriuretic Peptides: Accepted Knowledges or Changing Views?
Current Pharmaceutical Analysis Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research Fluorinated Mechanism-Based Inhibitors: Common Themes and Recent Developments
Current Topics in Medicinal Chemistry Cell and Gene Therapies for Refractory Epilepsy
Current Neuropharmacology Clinical Use of Intracoronary Gene Transfer of Fibroblast Growth Factor for Coronary Artery Disease
Current Gene Therapy Graphical Abstracts
Letters in Drug Design & Discovery